Abingdon Health Plc
ABDX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £5 | £3 | £4 | £2 |
| % Growth | 72.4% | -16.9% | 54.6% | – |
| Cost of Goods Sold | £3 | £2 | £1 | £1 |
| Gross Profit | £2 | £1 | £2 | £1 |
| % Margin | 41.4% | 29.6% | 60.7% | 53% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £6 | £2 | £2 | £3 |
| SG&A Expenses | £4 | £3 | £2 | £3 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | -£1 | £0 | £0 | -£0 |
| Operating Expenses | £4 | £3 | £2 | £3 |
| Operating Income | -£2 | -£2 | -£0 | -£1 |
| % Margin | -28.5% | -76.2% | -3.2% | -52% |
| Other Income/Exp. Net | £1 | -£0 | -£0 | £0 |
| Pre-Tax Income | -£1 | -£3 | -£0 | -£1 |
| Tax Expense | £0 | -£0 | -£0 | -£0 |
| Net Income | -£1 | -£3 | -£0 | -£1 |
| % Margin | -16.8% | -81.5% | -1.8% | -50% |
| EPS | -0.002 | -0.007 | -0 | -0.004 |
| % Growth | 66.2% | -3,450% | 95% | – |
| EPS Diluted | -0.002 | -0.007 | -0 | -0.004 |
| Weighted Avg Shares Out | 376 | 355 | 309 | 304 |
| Weighted Avg Shares Out Dil | 376 | 355 | 309 | 307 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£0 | -£2 | £0 | -£1 |
| % Margin | -8.9% | -75.2% | 7.1% | -37.4% |